9 funds hold both · as on May 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 9 mutual funds hold active equity positions in both Acutaas Chemicals and Orchid Pharma. The scheme with the highest combined exposure is Kotak Healthcare Fund (Kotak MF), which holds a 4.92% stake in Acutaas Chemicals and a 1.70% stake in Orchid Pharma, amounting to a combined conviction weight of 6.62%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Acutaas wt. | Orchid wt. | Combined |
|---|---|---|---|
| Kotak Healthcare FundKotak MF · Sectoral / Thematic | 4.92% | 1.70% | |
| Kotak Consumption FundKotak MF · Sectoral / Thematic | 4.91% | 1.36% | |
| Kotak MNC FundKotak MF · Sectoral / Thematic | 5.56% | 0.69% | |
| Tata India Innovation FundTata MF · Sectoral / Thematic | 2.60% | 0.82% | |
| UTI Small Cap FundUTI MF · Small Cap | 2.45% | 0.45% | |
| Kotak Multicap FundKotak MF · Multi Cap | 1.75% | 0.08% | |
| Kotak Multi Asset Allocation FundKotak MF · Hybrid | 1.21% | 0.54% | |
| Back to IndexMotilal Oswal MF · Index Fund | 0.95% | 0.07% | |
| Kotak Balanced Advantage FundKotak MF · Hybrid | 0.82% | 0.01% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on May 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.